# Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used

> **NCT02860299** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 76 (actual)

## Conditions studied

- Acute Renal Insufficiency

## Interventions

- **DRUG:** citrate 4%
- **DRUG:** unfractionated heparin
- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT02860299
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02860299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02860299, "Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02860299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*